Objective: The present study examined the effect of high-dose cefopera-zone-sulbactam combined with tigecycline against ventilator-associated pneumonia (VAP) caused by extensively drug-resistant Acinetobacter baumannii (XDR-AB). Materials and methods: 42 patients with VAP due to XDR-AB infection were randomized into two groups: the TIG group (received tigecycline injection) and the TIG+CFS group (received tigecycline and cefoperazone- sulbactam (1 : 1) injection). Pulsed field gel electrophoresis (PFGE) was used for genotyping the isolated XDR-AB. The microdilution method was used to test the minimum inhibitory concentration (MIC) of cefoperazone-sulbactam or tigecycline in vitro and the combined effect was determined with the checkerboard method. Results: The total combined effectiveness rate (including all patients who demonstrated an improved condition) was significantly higher in the TIG+CFS group (85.7%) compared with the TIG group (47.6%) (p = 0.010). No significant differences were noted with regard to the adverse reactions between the two groups. The 42 isolated XDR-AB strains were classified into four types. The MIC of the two drugs in combination was significantly lower than that of each drug used alone (p < 0.05). Conclusion: High dose of cefoperazone-sulbactam can improve the antimicrobial activity of tigecycline against XDR-AB.
14 July 2023 in Iranian Journal of Pharmaceutical Research
: In recent years, metal-organic frameworks (MOFs) have gained attention in the biomedical field, particularly as drug carriers for treating tumors. Therefore, we decided to synthesize a novel benzoic acid Zn-based MOF and study the Zn-based MOFs' drug-delivery properties and the drug-delivery system's anticancer effects. This study successfully synthesized a zinc-based MOF using solvent thermal synthesis. The crystal structure of a Zn-based MOF was investigated using thermogravimetric analysis, X-ray diffraction, and Fourier transform infrared spectroscopy. Subsequently, the results of UV spectrophotometry showed that Doxorubicin was successfully loaded with a loading amount of 33.74%. Furthermore, the drug release experiments demonstrated that the Zn-based MOF was pH-sensitive, releasing more at a pH of 3.8 than at pH 5.8 or 7.4. Finally, the Zn-based MOF loaded with drugs exhibited high antitumor activity against HepG2 cells while demonstrating remarkably low toxicity to normal cells (LO2). Taken together, these results demonstrate that the Zn-based MOF has the potential to serve as a carrier in the field of drug delivery systems.
25 February 2026 in Journal of Materials Science: Materials in Medicine
Mesoporous metal-organic frameworks (MOFs) have the advantages of high specific surface area, tunable pore size, and favorable biocompatibility, making them promising candidates for drug delivery in cancer therapy. In this study, a series of mesoporous zinc-based MOF, constructed using cyclopentane dicarboxylic acid as the organic linker, was successfully synthesized via a surfactant-assisted solvothermal method. Surface characterization revealed that MOF-2 exhibited high surface area (1325 m2/g), pore volume (0.273 cm3/g), and average pore diameter (5.69 nm). UV-Vis analysis showed that MOF-2 demonstrated improved drug loading (18% w/w), encapsulation efficiency (86%), and cumulative release (96%), along with both pH-responsive degradation and drug release properties. Furthermore, cisplatin-loaded MOF-2 exhibited potent antitumor activity against A549 cells and effectively inhibited cell migration and invasion, while maintaining minimal cytotoxicity toward LO2 normal hepatic cells. These findings suggest MOF-2 as a promising nanocarrier for pH-responsive anticancer drug delivery. Graphical Abstract
Myocardial fibrosis is the most serious complication of viral myocarditis (VMC). This study aimed to investigate the therapeutic benefits and underlying mechanisms of lentivirus-mediated human tissue kallikrein gene transfer in myocardial fibr...
Objective: To investigate the way in which prolylcarboxypeptidase (PRCP) protects against myocardial ischemia-reperfusion injury (MIRI) and the mechanisms that underlie it. Method: A surgical ligation of the coronary artery was adopted to establish a myocardial ischemia-reperfusion model in male SD rats. Thirty-six rats were randomly divided into six groups: Normal group, Sham group, MIRI model group, empty vector (MIRI + EZ.null) group, PRCP overexpression (MIRI + PRCP) group, and nicorandil (MIRI + Nic) group, with 6 rats in each group. The rats received an injection of PRCP's adeno-associated virus 9 (AAV9) through the tail vein 3 weeks prior to the modeling. Results: Compared with the Normal and Sham groups, the expression levels of NOD-like receptor thermal protein domain-associated protein 3 (NLRP3), Caspase-1, IL-18, IL-1β, and GSDMD in the MIRI group and MIRI + EZ-null group were significantly increased ( P < 0.05). Myocardial apoptosis index, myocardial infarction size, ejection fraction, and short axis shortening rate were significantly increased ( P < 0.05). At the same time, PRCP and nicorandil therapy could reverse the damage effect caused by MIRI ( P < 0.05). Conclusion: PRCP can lessen MIRI and protect cardiac function in rats by inhibiting NLRP3/Capase-1/IL-18/IL-1β signaling pathway-mediated cell pyroptosis.
Chinese yam, a plant used in traditional medicine and food, shows promise for treating osteoporosis, but its exact mechanism of action remains unclear. In this study, employs network pharmacology, molecular dynamics simulation techniques, and in vitro and in vivo experiments were employed to investigate the potential mechanisms underlying the therapeutic effects of Chinese yam on osteoporosis. Our study indicates that Chinese yam primarily exerts its effects primarily through several of its active components including Phytocassane A, Batatasin II, Gibberellin, Dihydroquercetin, Garcinone D, and Diosgenin. Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment revealed that the PI3K/Akt signaling pathway and MAPK signaling pathway were enriched with multiple targets, including EGFR, SRC, IL-6, AKT1, and CTNNB1. The results from molecular docking and molecular dynamics simulations revealed favourable binding stability of the target–compound complexes. Among them, Dihydroquercetin and Garcinone D demonstrated superior binding affinity for each target. In a zebrafish model demonstrated that Chinese yam extract effectively alleviated dexamethasone-induced inhibition of bone mineralization. We also found that Chinese yam extract increased alkaline phosphatase (ALP) activity, upregulated the protein expression of runt-related transcription factor 2 (RUNX2) and osteocalcin (OCN), and promoted PI3K phosphorylation in MC3T3-E1 cells treated with dexamethasone, and these effects could be reversed by a PI3K inhibitor (LY294002). This study revealed the active components and mechanisms underlying the efficacy of Chinese yam in treating osteoporosis, providing a theoretical foundation and research data for its clinical application in osteoporosis therapy.